Фонд RBV Capital продает портфельную компанию Bonti фармацевтическому производителю Allergan

We appreciate trust of our dear investors and we will follow further to that investment strategy which showed the efficiency. In our portfolio a number of perspective assets from which we expect serious return in the future remains